Illustrative image – not actual.Wockhardt Rhein Biopharm Ltd.
plans to raise the capacity of Hepatitis-B vaccine by eight times it current
production with the next one and half years. Ultimately, the company plans to
have a capacity of 50 million doses per year.
The company also plans to set up a biotechnology centre Waluj in Maharashtra for the production of the vaccine and human insulin.
